Definium Therapeutics (DFTX) Assets Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.75% |
| Dec 31, 2025 | 45.66% |
| Sep 30, 2025 | -25.91% |
| Jun 30, 2025 | -1.14% |
| Mar 31, 2025 | -0.08% |
| Dec 31, 2024 | 142.61% |
| Sep 30, 2024 | 125.91% |
| Jun 30, 2024 | 88.72% |
| Mar 31, 2024 | 77.16% |
| Dec 31, 2023 | -26.74% |
| Sep 30, 2023 | -21.76% |
| Jun 30, 2023 | 5.81% |
| Mar 31, 2023 | 4.22% |
| Dec 31, 2022 | 3.65% |
| Sep 30, 2022 | 1.30% |
| Jun 30, 2022 | -30.74% |
| Mar 31, 2022 | -25.68% |
| Dec 31, 2021 | 101.18% |
| Sep 30, 2021 | 654.05% |
| Jun 30, 2021 | 549.52% |
| Mar 31, 2021 | 665.63% |
| Dec 31, 2020 | -31.85% |